With the Health Sciences Authority approval of the Pfizer-BioNTech COVID-19 vaccine for emergency use in Singapore, the ...
The Health Sciences Authority (HSA) has granted an authorization 14 Dec 2020 under the Pandemic Special Access...
CEPI, the Coalition for Epidemic Preparedness Innovations, has announced a collaboration with South Korea-based SK Bio...
In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibo...
On the basis of scientific advice, the Australian Government has secured an additional 20 million doses of the promising...
Advanced MedTech Holdings (AMTH), a global medical technology leader headquartered in Singapore, announced today that th...
Bill & Melinda Gates Foundation has announced that it will commit an additional $250 million to support th...
Seoul Wei Fate, a leading provider of compound semiconductor solutions, in order to help prevent the spread of the virus...
A team of researchers from the National University of Singapore (NUS) has utilised a ground-breaking artificial int...
Singapore, like any other country, understands that the successful development of safe and efficacious vaccines is ...
Malaysia has announced funding of $3 million to the Coalition for Epidemic Preparedness Innovations (CEPI) to help suppo...
In an initiative to advance healthcare services with artificial intelligence, SAS, a leader in analytics, and Hewle...
The Australian Government’s early action to rapidly increase the number of skilled Registered Nurses (RN) to treat...
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. has announced that the extr...
Achiko AG, headquartered in Zurich, with offices in Hong Kong, Jakarta, Singapore and Seoul and Indonesia based Uda...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...
The International Vaccine Institute (IVI) and South Korean company EuBiologics exchanged an MOU to cooperate in the clin...
A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration ...
